BioNTech SE

Tweet this page
<
2020
2021
2022
2023
2024
>
Registration as it was on 14 Mar 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

100,000€ - 199,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.4 Fte (4)

Lobbyists with EP accreditation

0

High-level Commission meetings

5

Lobbying Costs over the years

  • Info

    BioNTech SE

    EU Transparency Register

    516273537966-42 First registered on 04 May 2020

    Goals / Remit

    Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline, including the Cominarty® Covid-19 vaccine and the first ever approved mRNA drug product.

    Main EU files targeted

    Interactions with the European Commission regarding activities relating to mRNA drugs and vaccines, including its COVID-19 vaccine.

    Address

    Head Office
    An der Goldgrube 12
    Mainz 55131
    GERMANY
    EU Office
    An der Goldgrube 12
    Mainz 55131
    GERMANY

    Website

  • People

    Total lobbyists declared

    4

    Employment timeLobbyists
    10%4

    Lobbyists (Full time equivalent)

    0.4

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 05 Nov 2024

    Name Start date End Date
    Ana PANCHEVSKA 12 Jan 2024 04 Oct 2024
    Constanze BLUME 12 Jan 2024 04 Oct 2024

    Complementary Information

    N/A

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    American Association for Cancer Research
    American Chamber of Commerce in Germany e.V.
    American Society for Mass Spectrometry
    American Society of Clinical Oncology
    American Society of Tropical Medicine and Hygiene
    Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V.
    Association of American Physicians
    Biotechnologie-Industrie-Organisation Deutschland e.V. (BIO Deutschland e. V.)
    Bundesdeutscher Arbeitskreis für Umweltbewusstes Management (B.A.U.M.) e.V.
    Bundesverband Materialwirtschaft, Einkauf und Logistik e.V. (BME)
    Chambre de Commerce et D’Industrie France-Amerique
    Cluster for Individualized Immune Intervention (Ci3) e.V.
    DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e.V.
    DIRK – Deutscher Investor Relations Verband e. V.
    DSAG - Deutschsprachige SAP-Anwendergruppe e.V.
    econsense – Forum Nachhaltige Entwicklung der Deutschen Wirtschaft e. V.
    European Confederation for Pharmaceutical Entrepreneurs (EUCOPE)
    European Society for Medical Oncology
    Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.
    gesundheitswirtschaft rhein-main e. V.
    Hessenchemie – Arbeitgeberverband Chemie und verwandte Industrien für das Land Hessen e. V.
    IHK - Industrie- und Handelskammer zu Berlin
    IHK - Industrie- und Handelskammer Halle-Dessau
    IHK - Industrie- und Handelskammer für Koblenz
    IHK - Industrie- und Handelskammer für München und Oberbayern
    IHK - Industrie- und Handelskammer für Rheinhessen
    International Society for Advancement of Cytometry
    International Society for Cell & Gene Therapy
    Initiative Gesundheitsindustrie Hessen (IGH)
    Kita Bio Regio e.V.
    Mainzer Wissenschaftsallianz e.V.
    Massachusetts Biotechnology Council
    Max Bergmann Kreis e.V.
    Project Management Institute
    Research Quality Association Ltd.
    Singapore Business Federation
    Society for Immunotherapy of Cancer
    The Alliance for mRNA Medicines (AMM)
    The American Association of Pharmaceutical Scientists
    The Foundation for the Global Compact
    The National Association for EHS&S Management
    Verband der Chemischen Industrie e.V. (VCI)
    Verband Forschender Arzneimittelhersteller e. V.; vfa
    Vereinigung für Sicherheit in der Wirtschaft e.V.
    Vienna BioCenter – Wissenschaftliche Standortgemeinschaft
    Women in Bio
    Zentrale zur Bekämpfung unlauteren Wettbewerbs e.V.

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    100,000€ - 199,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    kenup foundation 0€ - 10,000€
    fipra international srl 10,000€ - 24,999€

    Intermediaries for current year

    Name
    fipra international srl

    Closed year Costs

    100,000€ - 199,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    N/A

    Other activities

    None declared

  • Meetings

    Meetings

    5 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 22 Feb 2024 Location online
      Subject Presentation of their global health activities
      DG Directorate-General for International Partnerships
      Attending
      • Koen Doens (Director-General)
    • Date 27 Jun 2023 Location Brussels
      Subject social Europe, skills, industrial strategy
      Cabinet Cabinet of Commissioner Nicolas Schmit
      Portfolio Jobs and Social Rights
      Attending
      • Christoph Nerlich (Cabinet member)
    • Date 06 Jan 2022 Location Videoconference
      Subject Meeting with CEO of BioNTech
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Ursula von der Leyen (President)
    • Date 06 May 2021 Location Marburg Germany
      Subject Site visit and assessment of production capacity and supply chain
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Maurits-Jan Prinz (Cabinet member)
    • Date 31 Jan 2021 Location Videoconference
      Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Ursula von der Leyen (President)
      Other Lobbyists
Download this datacard